Fig. 1From: PEG-L-CHOP treatment is safe and effective in adult extranodal NK/T-cell lymphoma with a low rate of clinical hypersensitivityOverall survival curve in 33 patients with adult extranodal NK/T cell lymphoma. The patients were treated with PEG-L-CHOP every 21Â days for 6Â cycles. Follow-up data was collected and Kaplan-Meier survival analyses were performed. The overall survival rate at 1, 2, and 3Â year was 100, 90.61, and 80.54%, respectivelyBack to article page